ALX-0061

ALX-0061 · Ablynx, a Sanofi company

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ALX-0061, covering 2019-02-06 to 2019-08-21. Get the full timeline:

Most recent: Clinical Trial Update: A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid Arthritis [Phase 2]